{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:54:46Z","timestamp":1759694086745},"reference-count":0,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"vor","delay-in-days":14400,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[1976,8]]},"abstract":"<jats:p>Sulindac was tested for fecal blood loss in 40 healthy male subjects whose red cells had been labeled with Na<jats:sub>2<\/jats:sub><jats:sup>51<\/jats:sup>CrO<jats:sub>4<\/jats:sub>. Two daily dose levels of 240 mg and 400 mg were compared with 4.8 gm of aspirin and placebofor 2 wk. At day 15, aspirin\u2010induced blood loss was greater than that of both dose levels of sulindac and of placebo (p &lt; 0.05). There were no significant differences between the two sulindac groups and the placebo group. Aspirin caused more adverse reactions than sulindac, 240 mg (p &lt; 0.05), 400 mg (p &lt; 0.05), and placebo (p &lt; 0.05).<\/jats:p>","DOI":"10.1002\/cpt1976202238","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T01:42:01Z","timestamp":1451958121000},"page":"238-240","source":"Crossref","is-referenced-by-count":24,"title":["Intestinal blood loss after a new anti\u2010inflammatory drug, sulindac"],"prefix":"10.1111","volume":"20","author":[{"given":"Albert","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,4]]},"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt1976202238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt1976202238","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt1976202238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:34:31Z","timestamp":1699364071000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt1976202238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1976,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1976,8]]}},"alternative-id":["10.1002\/cpt1976202238"],"URL":"https:\/\/doi.org\/10.1002\/cpt1976202238","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[1976,8]]}}}